Biotech

All Articles

Basilea ratings $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's job creating new antifungals has gotten a notable increase from the U.S. De...

Capricor sells Europe civil liberties to late-stage DMD treatment for $35M

.Possessing already scooped up the USA legal rights to Capricor Therapies' late-stage Duchenne muscl...

FDA fragments adcomm for Applied's uncommon condition medicine

.After pushing back the choice date for Applied Therapies' metabolic condition medication govorestat...

Novo inks $600M NanoVation package to analyze genetic drugs ex-liver

.Novo Nordisk is proceeding its own press in to genetic medications, consenting to pay NanoVation Re...

Innovent links cytokine to intestines cancer actions

.Innovent Biologics has created the instance that its gate inhibitor-cytokine blend healthy protein ...

Merck, Daiichi ADC reaches objective in period 3 bronchi cancer research

.A period 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina grows AI focus with collab to pick cancer cells targets

.5 months after Rakovina Therapeutics pivoted towards artificial intelligence, the cancer-focused bi...

Ascendis' dwarfism medication hits in stage 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a possible risk to BioMarin's Voxzogo, reporting period 3 g...

Despite ph. 3 miss, Alkeus observes road ahead of time for eye health condition possession

.Though Alkeus Pharmaceuticals' dental eye health condition resource fell short to significantly min...

Kairos goes public along with $6M IPO to money trials of cancer drug

.Along with a triad of biotechs striking the Nasdaq on Friday, it was simple to overlook a smaller-s...